![]() | With appropriate antibiotic treatment, TB can be cured in more than nine out of 10 patients. |
Several different antibiotic drugs are given in combination for TB for at least 6 months, sometimes for 12 months or more.
Some strains of TB are resistant to a range of drugs (multidrug-resistant tuberculosis (MDR-TB)).
Treatment of MDR-TB requires the use of special TB drugs for up to 2 years.
However, the success rates of treatment in patients with MDR-TB are usually not as high as in patients infected by bacteria that are sensitive to treatment.
The increasing resistance of M. tuberculosis is currently a major concern.
Two types of treatment resistance can be found in TB-infected patients:
1. Resistance in patients newly infected with highly resistant TB strains, which is uncommon in most European regions.
2. Resistance in previously treated patients; this develops because of non-adherence to treatment, insufficient prescriptions, inadequate healthcare systems, insufficient drug supply, etc., which is very common, particularly in Eastern Europe.

Tuberculosis (TB) and Multidrug-resistant tuberculosis (MDR-TB)
The most effective means of prevention of TB in the community is the identification and treatment of infected individuals.
Treatment of latent TB infection can also prevent the development of active TB.
In those parts of the world where the disease is common, the World Health Organization (WHO) recommends that infants receive BCG vaccine, which may prevent TB from developing. However, its efficacy is only 50% over approximately 10 years.
Do you have a story related to lung disease that you would like to share?
Please go to our testimonies page and add your own